International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
Granzyme H Serum Levels Variations with Both Reproductive Hormone Receptors, and Related Hormone Receptors in Breast Cancer Patients
Abstract
Background: Breast Cancer (BC) is the most common cancer in Iranian women, meanwhile the Iranian patients are relatively young. Granzyme H (GZMH) is a functional cytotoxic serine protease of NK cell granules, which expands the cell death-inducing repertoire of innate immune system. GZMH is constitutively and highly expressed in human NK cells, in order to possess chymotrypsin-like (chymase) enzymatic activity. The purpose of this study was to determine GZMH level, in BC and healthy women.
Methods: 30 breast cancer patients, and 30 control women in premenopausal status, have participated in this study. GZMH, Estrogen levels, and ER, PR have been measured in cancer and healthy women subsequently, as using ELISA, Radioimmunoassay, and Immunohistochemistry methods.
Results: Mean GZMH value was lower in BC than healthy women (p<0.0001).
Conclusion: Our study has implicated existence of suppressor or problem for producing of GZMH in patients group and levels of estrogen couldn’t effect on making positive ER, PR.
Copyright
© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Granzyme B Level in Acute Renal Transplant Rejection
Zarghami N, Samadzadeh S, Fani H, Alani B. Granzyme B Level in Acute Renal Transplant Rejection. J Kermanshah Univ Med Sci. 2007;11(1):e81861. doi:
The Differences of Age, Tumor Grade, and Her2 Amplification in Estrogen and Progesterone Receptor Status in Patients with Breast Cancer
Sheikhpour E, Taghipour S. The Differences of Age, Tumor Grade, and Her2 Amplification in Estrogen and Progesterone Receptor Status in Patients with Breast Cancer. Int J Cancer Manag. 2018;11(8):e9492. doi: https://doi.org/10.5812/ijcm.9492
Comparison of ER, PR, Ki67 and HER-2/neu Reactivity Pattern with Patients’ Age, Histologic Grade, Tumor Size and Lymph Node Status in Invasive Ductal Breast Cancer
Ahadi M, Heibatollahi M, Zahedifard S. Comparison of ER, PR, Ki67 and HER-2/neu Reactivity Pattern with Patients’ Age, Histologic Grade, Tumor Size and Lymph Node Status in Invasive Ductal Breast Cancer. Int J Cancer Manag. 2020;13(6):e98325. doi: https://doi.org/10.5812/ijcm.98325
The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors
Taghizadeh-Kermani A, Jafarian AH, Ashabyamin R, Seilanian-Toosi M, Pourali L, et al. The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors. Int J Cancer Manag. 2014;7(1):e80503. doi:
Clinicopathologic Features and Prognostic Role of CD3, CD8, and PD-1 positive Tumor-Infiltrating Lymphocytes and the Association with COX-2 Overexpression in Endometrial Carcinoma
Nobari N, Niknejad N, Poorolajal J, Vaezi M, Nili F, et al. Clinicopathologic Features and Prognostic Role of CD3, CD8, and PD-1 positive Tumor-Infiltrating Lymphocytes and the Association with COX-2 Overexpression in Endometrial Carcinoma. Int J Cancer Manag. 2020;13(4):e99210. doi: https://doi.org/10.5812/ijcm.99210
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 5
Last Update: 2 weeks ago
- Scopus by Title (Ref): 5
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 5 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):